08 Jun 2021Ended

Navigating the Choppy Waters of Implementing Rapid Molecular Blood Culture Identification Tests


Estimated Turnout

upto 100
Based on previous editions


Jun 2021


Not Available
Claim event to edit details

The implementation process for rapid molecular blood culture identification can be a complex process for laboratories, medical staff  and the .. Read more antimicrobial stewardship program (ASP). By partnering with institutions to provide a comprehensive solution focused on patient-centered-care and antimicrobial stewardship throughout implementation, we can help you stay above the water while adopting a rapid molecular test for diagnosis of bacterial and fungal pathogens causing bloodstream infections. For any new test, there are several factors to consider both on the laboratory and the stewardship side. The laboratory must consider how to incorporate the new test into their current blood culture workflow, when to perform the test, what the quality control and quality assurance plan will be, how to report the results and who to report them to, how the results will be reported into the laboratory LIS and hospital EHR and lastly, how and when to educate the clinicians. The IDSA/SHEA guidelines recommend that ASPs develop processes and interventions that assist clinicians in interpreting and responding appropriately to results from rapid diagnostic testing on blood cultures.1 One method of accomplishing this is by using customizable comments along with rapid diagnostic test reporting. A cohesive partnership between the laboratory, ASP and GenMark Infectious Disease Specialists (IDS) has proven to be an effective approach to addressing the challenges with the implementation of blood culture identification (BCID) rapid tests.

  • Share your Experience
  • Organizer
Logo Follow Company


Canada463 Total Events / 23 Upcoming Events

More Events From The Organizer

You have no contacts. Please add contacts from below or share on social media

Send to all
No Results